Dalal Street Blogs provides information for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
CAUTION: Dalal Street Blogs publishes market news and educational content only. We do not promote, recommend or endorse any stock, and nothing here is a solicitation to buy or sell securities. Please consult a SEBI-registered adviser before investing.

Indian Stock Market News, Analysis and Trading Guides

News

Sudarshan Chemical Credit Rating October 2026: India Ratings Turns Outlook Positive on Heubach Turnaround

Sudarshan Chemical credit rating: trays of bright red, yellow, blue and green pigment powders

Photo: fietzfotos via Pixabay (2924891)

By Dalal Street Blogs Editorial3 min read

The Sudarshan Chemical credit rating didn’t change on paper, but the direction did. In a filing on October 20, 2026, the Pune-based pigment maker said India Ratings and Research (Ind-Ra) had revised the outlook on its debt facilities to Positive from Stable, while affirming the ratings at IND AA for long-term bank loans and fixed deposits and IND A1+ for short-term bank loans and commercial paper. The agency’s release is dated October 19.

A positive outlook is a signal, not an upgrade. It tells lenders the agency sees a real chance of moving the rating up if things keep going the way they are. So the useful question is what “the way things are going” actually looks like.

What sits behind the Sudarshan Chemical credit rating outlook change

Almost all of it comes back to Heubach, the German pigment group Sudarshan bought in March 2025. Ind-Ra says the deal has made the company the second-largest pigment producer in the world, with 19 manufacturing sites across five continents, against two facilities in India before the acquisition. The product basket has grown to around 1,600 products from about 695.

The numbers in the rationale show how big that shift is:

  • Consolidated revenue was around ₹98 billion in FY26, roughly 200% higher than FY25.
  • The acquired Heubach group contributed about ₹70 billion of that, while the legacy pigment business was flat at about ₹26 billion.
  • Consolidated EBITDA (excluding other income) rose to ₹5.9 billion from ₹3.8 billion in FY25, which Ind-Ra puts at a 55% increase.
  • Heubach’s own EBITDA climbed to ₹1.46 billion in Q1 FY27, from ₹0.78 billion in Q1 FY26.

That last line is the turnaround the agency is betting on. Heubach was bought out of insolvency, and in FY26 it generated EBITDA of only EUR 13 million against guidance of EUR 35 million. Ind-Ra takes comfort from the recovery over the two quarters to June 2026, and notes the company expects the business to hit EUR 35 million in FY27 and scale up to EUR 90 million by FY29.

The upgrade case rests on a German turnaround and a Frankfurt plant sale, not on the old Indian business.

The Frankfurt sale and the debt picture

The second leg is deleveraging. Sudarshan is selling its stake in VP4 Frankfurt GmbH, a non-core step-down subsidiary, for EUR 76.5 million (about ₹8.4 billion), with the money largely going to prepay acquisition debt. Ind-Ra expects the deal to close in Q3 FY27 and the company to be net debt neutral at the consolidated level by end-FY27.

Net debt was already falling, from ₹7.5 billion at end-FY26 to ₹5.3 billion at end-Q1 FY27. Net leverage (net debt to EBITDA) eased to 1.3x in FY26 from 1.9x in FY25. Bank loan limits rated by the agency were trimmed to ₹5,240.60 million from ₹5,569.50 million.

What could slow it down

We wouldn’t treat the positive outlook as a done deal. Ind-Ra itself calls the pace and stability of profit improvement a key monitorable. It expects some margin moderation over the next few quarters because of higher production and logistics costs tied to geopolitical issues, and it says Europe, a key market, still faces demand and cost headwinds.

The trigger for an upgrade is spelled out: a sustained rise in scale and profitability, with net adjusted leverage (including acceptances) staying below 1.0x. Leverage above 1.0x on a sustained basis, from weaker profits or higher capex or working capital, would be the negative trigger. For a closer look at how other companies fared with rating agencies this week, see our pieces on the Karamtara Engineering upgrade and the TVS Motor reaffirmation. Our guide on how to analyse quarterly results will help when Sudarshan reports its next numbers.

Source: the Sudarshan Chemical filing on NSE, which encloses the full rationale, and the India Ratings press release. Live prices are on the NSE quote page.

Disclaimer: This article is for information and education only and is not investment advice. Please consult a SEBI-registered adviser before making investment decisions.

Leave a Reply

Join the conversation

Commenting is open to registered readers. Sign up with just your email — no password needed, and it takes under a minute.

Sign up to comment Log in